31P MR spectroscopic assessment of muscle in patients with myasthenia gravis before and after thymectomy: Initial experience

Radiology

Volumn 247, Issue 1, 2008, Pages 162-169

  Ko, Sheung Fat ^a   Huang, Chung Cheng ^a   Hsieh, Ming Jang ^a   Ng, Shu Hang ^a   Lee, Chen Chang ^a   Lee, Chih Chia ^a   Lin, Tsu Kung ^a   Chen, Min Chi ^a   Lee, Liangshiu ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MUSCLE METABOLISM; MYASTHENIA GRAVIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THYMECTOMY; TREATMENT RESPONSE; ADOLESCENT; CHEMISTRY; METABOLISM; MIDDLE AGED; MUSCLE ISOTONIC CONTRACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; FEMALE; HUMANS; ISOTONIC CONTRACTION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; PHOSPHATES; PHOSPHOCREATINE; THYMECTOMY;

EID: 42449141070     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2471070591     Document Type: Article

References (30)

1. Osserman KE, Genkins G. Studies in myasthenia gravis: a review of 20-year experience in over 1200 patients. Mt Sinai J Med 1971;38(6):497-537.
2. Schalke BCG, Hofmann E, Kaiser W. Disorders of the neuromuscular junction. In: Fleckenstein JL, Crues JV III, Reimers CD, eds. Muscle imaging in health and disease. New York, NY: Springer-Verlag, 1996; 215-218.
3. Drachman DB. Myasthenia gravis and other diseases of the neuromuscular junction. In: Braunwald E, Fauci AS, Kasper DL, Huaser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. 15th ed. New York, NY: McGraw-Hill, 2001; 2515-2520.
4. Nicolaou S, Muller NL, Li DK, Oger JJ. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology 1996;201(2):471-474.
5. Batra P, Herrmann C Jr, Mulder DM. Mediastinal imaging in myasthenia gravis: correlation of chest radiography, CT, MR and surgical findings. AJR Am J Roentgenol 1987;148(3):515-519.
6. Moore NR. Imaging in myasthenia gravis. Clin Radiol 1989;40(2):115-116.
7. Frist WH, Thirumalai S, Doehring CB, et al. Thymectomy for myasthenia gravis patients: factors influencing outcome. Ann Thorac Surg 1994;57(2):334-338.
8. Lopez-Cano M, Ponseti-Bosch JM, Espin-Basany E, Sanchez-Garcia JL, Armengol-Carrasco M. Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis. Ann Thorac Surg 2003;76(5):1643-1649.
9. Ozdemir N, Kara M, Dikmen E, et al. Predictors of clinical outcome following extended thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 2003;23(2):233-237.
10. Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest: methods and variance of values. Scand J Clin Lab Invest 1974;33(2):109-120.
11. Lanza IR, Befory DE, Kent-Braunm JA. Age-related changes in ATP-producing pathways in human skeletal muscle in vivo. J Appl Physiol 2005;99(3):1736-1744.
12. McCully K, Mancini D, Levine S. Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems. Chest 1999;116(5):1434-1441.
13. Kemp GJ. Studying metabolic regulation in human muscle. Biochem Soc Trans 2000;28(2):100-103.
14. Kemp GJ, Thompson CH, Bares PR, Radda GK. Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy. Magn Reson Med 1994;31(2):248-258.
15. Sullivan MJ, Saltin B, Negro-Vilar R, Duscha BD, Charles HC. Skeletal muscle pH assessed by biochemical and 31P-MRS methods during exercise and recovery in men. J Appl Physiol 1994;77(5):2194-2200.
16. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 1991;41(1):114-120.
17. Argov Z, Arnold DL. MR spectroscopy and MR imaging in metabolic myopathies. Neurol Clin 2000;18(1):35-52.
18. Argov Z, Bank WJ. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol 1991;30(1):90-97.
19. Korenyi-Both A, Szobor A, Lapis K, Szathmary I, Kerpel-Fronius S. Fine structural studies in myasthenia gravis. I. Muscle fibre lesions. Eur Neurol 1973;10(4):215-236.
20. Marchiori PE, Levy JA, Carvalho-Alegro MS, et al. Mitochondrial dysfunction in myasthenia gravis: report of a case. Arq Neuropsiquiatr 1989;47(3):355-358.
21. Chiriac LM, Biro L, Vargulescu D, Onofrei T, Fogel ME. The clinico-anatomical aspects of myasthenia gravis [in Romanian]. Rev Med Chir Soc Med Nat Iasi 1991;95(1-2):59-61.
22. Plewnia K, Dotti MT, Malandrini A, et al. A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case. J Submicrosc Cytol Pathol 1997;29(3):335-338.
23. Rostedt Punga A, Ahlqvist K, Bartoccioni E, et al. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 2006;117(7):1434- 1443.
24. Schunk K, Losch O, Kreitner KF, Kersjes W, Schadmand-Fischer S, Thelen M. Contributions of dynamic phosphorus-31 magnetic resonance spectroscopy to the analysis of muscle fiber distribution. Invest Radiol 1999;34(5):348-356.
25. Mannix ET, Boska MD, Galassetti P, Burton G, Manfredi F, Farber MO. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS. J Appl Physiol 1995;78(6):2218-2227.
26. Weiss RG, Gerstenblith G, Bottomey PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A 2005;102(3):808-813.
27. Jacobsen EB, Hamberg O, Quistorff B, Ott P. Reduced mitochondrial adenosine triphosphate synthesis in skeletal muscle in patients with Child-Pugh class B and C cirrhosis. Hepatology 2001;34(1):7-12.
28. Vandenborne K, McCully K, Kakihira H, et al. Metabolic heterogeneity in human calf muscle during maximal exercise. Proc Natl Acad Sci U S A 1991;88(13):5714-5718.
29. Argov Z, Bank WJ, Maris J, Peterson P, Chance B. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987;37(2):257-262.
30. Kuhl CK, Layer G, Traber F, Zierz S, Block W, Reiser M. Mitochondrial encephalomyopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 1994;192(1):223-230.